FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Guidance on Labeling Blood Lancets

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on labeling recommendations for blood lancets that the devices be used for only a...

Guidance on Impurities in Drug Products

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on ANDAs: Impurities in Drug Products.

Guidance on Antibacterial Drug Products

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance, Antibacterial Drug Products: Use of Noninferiority Trials to Support Approval.

The Medicines Co. Agrees on Oritavancin Trials

[ Price : $8.95]

The Medicines Company reaches agreement with FDA under a Special Protocol Assessment on Phase 3 clinical trials for oritavancin in...

Advisors to Consider Avodart, Proscar Prostate Cancer Prevention

[ Price : $8.95]

FDA reviewers question the relevance of clinical trials submitted to support labeling changes for Avodart and Proscar relating the...

Gen-Probe Submits PMA for HPV Assay

[ Price : $8.95]

Gen-Probe files a PMA for its Aptima HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections ...

FDA Extends Review for MS Drug

[ Price : $8.95]

FDA extends by three months its review of an EMD Serono NDA for cladribine tablets as a therapy for relapsing forms of multiple sc...

FDA Sees Need to Improve NDC Directory

[ Price : $8.95]

FDA says it generally agrees with an HHS Inspector General recommendation that it do a better job of ensuring completeness and acc...

Sanofi Pasteur Trial Begins with C-diff Vaccine

[ Price : $8.95]

Sanofi Pasteur starts a Phase 2 clinical study involving a vaccine for primary prevention of Clostridium difficile infection.

Spectrum Pharma Resubmits sNDA for Fusilev

[ Price : $8.95]

FDA accepts for review a Spectrum Pharmaceuticals supplemental NDA re-submission for Fusilev (levoleucovorin) for injection for tr...